SEC Filings TLDR

On October 23, 2025, Kemble Morrison, VP-Corporate Controller of Vicor Corp, engaged in multiple transactions involving the company's common stock and non-qualified stock options. Morrison acquired 1,361 shares of common stock at $41.61 per share and later disposed of the same number of shares at $91.94 per share. Addi...

Claudio Tuozzolo, Corporate Vice President of Vicor Corp, engaged in multiple stock transactions on October 23, 2025. These transactions included both acquisitions and disposals of common stock, as well as the exercise of non-qualified stock options. Tuozzolo acquired a total of 14,637 shares of common stock at various...

On October 23, 2025, Estia J. Eichten, a director of Vicor Corp, engaged in several transactions involving the company's common stock. Eichten sold 5,000 shares at $91.2465 per share, acquired 4,713 shares at $10.61 per share, and sold an additional 555 shares at $91.0071 per share. Additionally, Eichten exercised a no...

Mat Ishbia, President and CEO of UWM Holdings Corp, along with SFS Holding Corp, a 10% owner of the company, have reported the sale of Class A Common Stock. The transactions occurred on October 23, 24, and 27, 2025, with a total of 1,789,068 shares sold at weighted average prices of $5.75, $5.87, and $5.83 per share, r...

On October 23, 2025, Ding Xia, a director of USANA Health Sciences Inc., engaged in several transactions involving the company's common stock and restricted stock units. Xia acquired 1,057 shares of common stock at $0 per share, increasing his total holdings to 6,394 shares. He also disposed of 476 shares at $20.63 per...

John Turman Fleming, a director of USANA Health Sciences Inc., reported transactions involving the company's common stock and restricted stock units. On October 23, 2025, Fleming acquired 1,057 shares of common stock, increasing his total holdings to 6,315 shares. On the same date, he disposed of 1,057 restricted stock...

Nixon J Scott, a director of USANA Health Sciences Inc, reported transactions involving Restricted Stock Units (RSUs) and Common Stock on October 23, 2025. The RSUs represent a contingent right to receive one share of USNA common stock and are set to vest in four equal installments between July 24, 2025, and April 23, ...

Frederic J Winssinger, a director of USANA Health Sciences Inc, reported transactions involving the company's common stock and restricted stock units on October 23, 2025. Winssinger acquired 1,057 shares of common stock, increasing his total holdings to 7,986 shares. Additionally, he disposed of 1,057 restricted stock ...

On October 23, 2025, Timothy E. Wood, a director of USANA Health Sciences Inc., engaged in several transactions involving the company's common stock and restricted stock units. Wood acquired 1,057 shares of common stock at $0 per share, increasing his total holdings to 9,292 shares. He also disposed of 265 shares of co...

On October 23, 2025, Gilbert A. Fuller, a director of USANA Health Sciences Inc., engaged in a transaction involving Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of USNA common stock. The transaction involved the disposition of 1,057 RSUs, resulting in Fuller owning 2,115 R...

Pelosi Peggie, a director of USANA Health Sciences Inc., reported several transactions on October 23, 2025. She acquired 1,057 shares of common stock at $0 per share, increasing her total holdings to 5,192 shares. On the same day, she disposed of 606 shares of common stock at $20.63 per share, reducing her holdings to ...

On October 20, 2025, Universal Safety Products, Inc. granted 25,000 stock options to its Chief Financial Officer, James Ballard Huff. The options, which are exercisable at a price of $3.40 per share, were granted on August 27, 2025, and vested upon stockholder approval on October 20, 2025. The options are exercisable o...

On September 9, 2024, Christopher Causey, a director of United Therapeutics Corp, reported the transfer of 225 shares of common stock from an account jointly held with his son to an account in which he has no beneficial interest. This transfer was done without his knowledge and was discovered recently, leading to an ov...

Martine A. Rothblatt, Chairperson & CEO of United Therapeutics Corp, engaged in multiple stock transactions between October 23 and October 24, 2025. These transactions included the acquisition and disposal of common stock and stock options. Notably, Rothblatt exercised stock options for 4,000 shares at $120.26 per shar...

Shu Pei Huang Desmond, the Acting Group CFO of Triller Group Inc., acquired 2 million shares of common stock on October 21, 2025. This transaction was part of a grant under the Triller Group Inc. 2024 Equity Incentive Plan. Following this acquisition, Desmond's total holdings in the company increased to 2,509,684 share...

Ng Wing Fai, the Chief Executive Officer and Director of Triller Group Inc., acquired 4,000,000 shares of common stock on October 21, 2025. This transaction was conducted under the Triller Group Inc. 2024 Equity Incentive Plan. Following this acquisition, Ng Wing Fai's total ownership in the company increased to 11,336...

On October 21, 2025, Wong Yun Pun Felix, a director of Triller Group Inc., acquired 500,000 shares of common stock under the Triller Group Inc. 2024 Equity Incentive Plan. This transaction was reported in a Form 4 filing with the SEC. Following this acquisition, Wong Yun Pun Felix owns a total of 596,225 shares of Tril...

On October 21, 2025, Ng Thomas Kwok On, a director of Triller Group Inc., acquired 500,000 shares of the company's common stock. This transaction was conducted under the Triller Group Inc. 2024 Equity Incentive Plan. Following this acquisition, Ng Thomas Kwok On's total holdings in the company increased to 654,920 shar...

On October 21, 2025, Brian Chung Yau Chan, a director of Triller Group Inc., was granted 500,000 shares of common stock under the Triller Group Inc. 2024 Equity Incentive Plan. This transaction increased his total holdings to 591,500 shares. The grant was made at a price of $0 per share, as indicated in the filing. The...

On October 24, 2025, Amandine Robin-Caplan, the Chief Brand and Communications Officer of Travel & Leisure Co., sold 1,538 shares of the company's common stock at a price of $65.08 per share. Following this transaction, Robin-Caplan's direct ownership in the company decreased to 3,904 shares. Additionally, she holds 32...

Jeffrey Myers, the Chief Sales and Marketing Officer of Vacation Ownership at Travel & Leisure Co., has sold a significant number of shares in the company. The transactions occurred on October 23 and October 27, 2025. On October 23, Myers sold 21,362 shares at a weighted average price of $66.16, 7,102 shares at $68.48,...

Anutthara Bharadwaj, a director at Toast, Inc., was granted 10,699 Restricted Stock Units (RSUs) on October 24, 2025. These RSUs convert into Class A Common Stock on a one-for-one basis upon vesting and settlement. The RSUs will vest in three equal annual installments starting on October 24, 2026. The transaction was r...

On October 24, 2025, Horizon Kinetics Asset Management LLC (HKAM) acquired 1 additional share of Texas Pacific Land Corp (TPL) common stock at a price of $949.13 per share. This transaction increased HKAM's total holdings to 1,162,551 shares. HKAM is a ten percent owner of TPL and holds these shares directly. The filin...

On October 23, 2025, Third Rock Ventures IV, L.P. sold 477,401 shares of Tango Therapeutics, Inc. common stock at a weighted average price of $10.152 per share. The shares were sold in multiple transactions at prices ranging from $10.00 to $10.65. Following this transaction, Third Rock Ventures IV, L.P. still holds 13,...

Wilson Donta L, Chief Consumer & SB BK Officer of Truist Financial Corp (TFC), reported a transaction involving 230 shares of common stock on October 23, 2025. The shares were disposed of at a price of $0 per share, leaving Donta L with 56,009.099 shares directly owned. Additionally, Donta L holds 6,781.694 shares indi...